Supernus Announces Second Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St rises on AI gains as oil slides, Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips below $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
Supernus Pharmaceuticals (SUPN) PT Lowered to $50 at Cowen
August 7, 2019 10:32 AM EDTCowen analyst Ken Cacciatore lowered the price target on Supernus Pharmaceuticals (NASDAQ: SUPN) to $50.00 (from $55.00) while maintaining an Outperform rating.
The analyst commented, "Q2 results indicate what has been long building, which is that Trokendi & Oxtellar are showing the natural aging process, and... More
